Baricitinib is a pyrrolopyrimidine compound that functions as a selective inhibitor of Janus kinases 1 and 2. It is used as a pharmaceutical raw material in the manufacture of immunosuppressive and anti-inflammatory medications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1187594-09-7
Phosphoric acid--{1-(ethanesulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile (1/1)
pharmaceutical raw material
Upadacitinib
pharmaceutical raw material
Abrocitinib
pharmaceutical raw material
Peficitinib
pharmaceutical raw material
Modafinil sulfone
pharmaceutical raw material
L-Acetylleucine
pharmaceutical raw material
Carglumic acid
pharmaceutical raw material
Norfloxacin nicotinate
pharmaceutical raw material
2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
XUZMWHLSFXCVMG-UHFFFAOYSA-N
CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3